HMTXF OTC
Hemostemix Inc
1W: -13.1%
1M: -20.9%
3M: +16.1%
YTD: -30.7%
1Y: -38.1%
3Y: -51.8%
5Y: -80.4%
$0.04
-0.00 (-0.08%)
Weekly Expected Move ±7.4%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$2M
-34.0% ▼
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$2M
-34.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$550K
+2697.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$8M | -$6M | -$5M | -$3M | -$3M |
| Depreciation & Amort. | $2K | $1K | $495 | $223 | $100 |
| Stock-Based Comp. | $2M | $362K | $179K | $150K | $331K |
| Change in Working Capital | -$826K | $3M | -$2M | $555K | -$232K |
| Other Non-Cash Items | $106K | -$114K | $173K | $378K | $615K |
| Operating Cash Flow | -$6M | -$3M | -$6M | -$1M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $171K | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $171K | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | -$2M | $2M | $3M | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$707K | -$72K | -$184K | -$65K | $0 |
| Financing Cash Flow | $6M | $3M | $6M | $1M | $2M |
| Net Change in Cash | $234K | -$39K | -$84K | $20K | $550K |
| Cash End of Period | $258K | $219K | $136K | $155K | $706K |
| Free Cash Flow | -$6M | -$3M | -$6M | -$1M | -$2M |